Dr. Redei is an Entrepreneur-in-Residence with two decades of experience in healthcare technology, the pharmaceutical industry, and academia; he is also Co-Founder and CTO of i2Dx, Inc., a Neuro-focused Big Data Analytics company. Dr. Redei is a former University of California, San Francisco faculty member and holds an M.D., as well as a Ph.D. in Applied Neuroinformatics. He comes to Biomark Capital following stints at Burrill & Company and Roche/Genentech, a leader in personalized healthcare.
Previously Dr. Redei headed clinical and imaging informatics at Roche for all six therapeutic areas globally, including CNS. At Roche, he was instrumental in developing a number of group-wide emerging IT strategies and implemented the company’s first forays into on-demand/cloud computing for clinical applications, and digital health. He also led the informatics effort of a consortium of five pharma companies to enable disease understanding, incorporating biosample, imaging, and clinical data sources from around the globe.